Since decreased ASS1 activity results in hyperammonemia and hypercitrullinemia, we first studied whether NH4+max and peak plasma L‐citrulline concentrations during the first metabolic decompensation are associated with residual enzymatic ASS1 activity. The gene discussed is ASS1; the disease is Hyperammonemia.